Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for ca...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
NCT00131014 · Non-Hodgkin's Lymphoma, Hodgkin's Disease, and more
NCT05346809 · Lymphoma, Multiple Myeloma, and more
NCT03500133 · Pediatric Hodgkin's Disease
NCT05595447 · Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, and more
NCT00368082 · Lymphoma, Hodgkin's Disease, and more
Brigham and Women's Hospital
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions